Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Genetically Modified Pig Models for Neurodegenerative Disorders.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation.
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.
Adult-Onset Leukoencephalopathies.
Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
Waldenstrom's Macroglobulinaemia Presenting as Demyelinating Polyradiculoneuropathy.
Accumulation of Fascin+ cells during experimental autoimmune neuritis.
Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia.
Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Neurotoxocarosis alters myelin protein gene transcription and expression.
Moyamoya disease in a patient with neuromyelitis optica.
Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.
Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases.
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Analysis of HLA-DQB1*0602 in Multiple Sclerosis Patients in Khuzestan Province, Iran.
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.
Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome.
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.
The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »